Gaman Health Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 23.70%
(FY 2023)
- Profit 242.58%
(FY 2023)
- Ebitda 299.30%
(FY 2023)
- Net Worth 11.60%
(FY 2023)
- Total Assets 8.55%
(FY 2023)
About Gaman Health Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Brindavana Palepu, Venumadhav Kavarthapu, Samsani Srinivasa, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110TG2011PTC077318
- Company No.
077318
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gaman Health Care?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samsani Srinivasa  | Director | 09-Nov-2011 | Current |
Sarath Veeravalli  | Director | 09-Nov-2011 | Current |
| Brindavana Palepu | Director | 09-Nov-2011 | Current |
Venumadhav Kavarthapu  | Director | 09-Nov-2011 | Current |
| Sujatha Yerramsetti | Director | 09-Nov-2011 | Current |
| Kandikattu Sreekanth | Director | 09-Nov-2011 | Current |
Financial Performance of Gaman Health Care.
Gaman Health Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.7% increase. The company also saw a substantial improvement in profitability, with a 242.58% increase in profit. The company's net worth Soared by an impressive increase of 11.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gaman Health Care?
Unlock access to Gaman Health Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Axon Anaesthesia Associates Private LimitedActive 22 years 8 monthsBrindavana Palepu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gaman Health Care?
Unlock and access historical data on people associated with Gaman Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gaman Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gaman Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
